Use of vascular closure device is safe and effective in electrophysiological procedures

Journal of Interventional Cardiac Electrophysiology

Volumn 43, Issue 2, 2015, Pages 193-195

  Maraj, Ilir ^a   Budzikowski, Adam S ^a   Ali, Waleed ^b   Mitre, Crisitina A ^a   Kassotis, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGSBROOK JEWISH MEDICAL CENTER   (United States)

Author keywords

Angioseal; Anticoagulation; Collagen vascular closure device; Venous access

Indexed keywords

HEPARIN; WARFARIN; ANTICOAGULANT AGENT; COLLAGEN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; ECCHYMOSIS; ELECTROPHYSIOLOGICAL PROCEDURES; FEMALE; FEMORAL VEIN; FOLLOW UP; HUMAN; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; HEART FUNCTION TEST; HEMOSTATIC TECHNIQUE; TREATMENT OUTCOME;

ANTICOAGULANTS; COLLAGEN; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR CLOSURE DEVICES;

EID: 84933670768     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-015-0005-5     Document Type: Article

References (10)

1. Dangas, G., Mehran, R., Kokolis, S., Feldman, D., Satler, L. F., Pichard, A. D., et al. (2001). Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. Journal of the American College of Cardiology, 38(3), 638–641.
2. Resnic, F. S., Blake, G. J., Ohno-Machado, L., Selwyn, A. P., Popma, J. J., & Rogers, C. (2001). Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. American Journal of Cardiology, 88(5), 493–496.
3. Coto, H. A. (2002). Closure of the femoral vein puncture site after transcatheter procedures using Angio-Seal. Catheterization and Cardiovascular Interventions, 55(1), 16–19.
4. Shaw, J. A., Dewire, E., Nugent, A., & Eisenhauer, A. C. (2004). Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheterization and Cardiovascular Interventions, 63(4), 439–443.
5. Hamid, T., Rajagopal, R., Pius, C., Clarke, B., & Mahadevan, V. S. (2013). Preclosure of large-sized venous access sites in adults undergoing transcatheter structural interventions. Catheterization and Cardiovascular Interventions, 81(4), 586–590.
6. Srivatsa, S. S., Srivatsa, A., & Spangler, T. A. (2015). Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model. Journal of Invasive Cardiology, 27(2), 121–127.
7. Bangard, C., Chang, D. H., Libicher, M., Bovenschulte, H., Kochanek, M., Reuter, H., et al. (2013). Misplacement of central venous catheters in the subclavian artery: Safe retrieval with a percutaneous closure device (AngioSeal). Röfo, 185(6), 546–549.
8. Mylonas, I., Sakata, Y., Salinger, M., Sanborn, T. A., & Feldman, T. (2006). The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access. Journal of Invasive Cardiology, 18(7), 299–302.
9. Chu, Y. Q., Cai, L. J., Jiang, D. C., Jia, D., Yan, S. Y., & Wang, Y. Q. (2010). Allergic shock and death associated with protamine administration in a diabetic patient. Clinical Therapeutics, 32(10), 1729–1732.
10. Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., et al. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.